Search / Trial NCT06221605

Regulation of Intestinal Flora by Compound Probiotics in Patients With Chronic Hepatitis B

Launched by WECARE PROBIOTICS CO., LTD. · Jan 23, 2024

Trial Information

Current as of December 21, 2024

Not yet recruiting

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Meet the hepatitis B clinical diagnostic criteria of the Chronic Hepatitis B Prevention and Treatment Guidelines (2022 edition), excluding patients infected with hepatitis C virus, hepatitis D virus and other hepatitis viruses;
  • 2. Be aware of the content and purpose of this study, and voluntarily sign the treatment study consent.
  • Exclusion Criteria:
  • 1. Patients infected within 3 months;
  • 2. Received antibiotic treatment within 3 months;
  • 3. Received probiotic and probiotic therapy within 3 months;
  • 4. Complicated with hypertension or diabetes;
  • 5. Obesity or significantly low weight;
  • 6. Obvious atherosclerosis;
  • 7. Chronic kidney disease;
  • 8. Inflammatory bowel disease, irritable bowel syndrome, or a history of gastrointestinal surgery;
  • 9. Malignant tumors;
  • 10. Autoimmune diseases;
  • 11. Mental illnesses such as Parkinson's disease, Alzheimer's disease and stroke;
  • 12. Pregnant or lactating women;
  • 13. Patients with cirrhosis or decompensated liver disease;
  • 14. Subjects cannot participate in the experiment due to their reasons; Those who meet any of the above criteria will not be selected.

About Wecare Probiotics Co., Ltd.

wecare probiotics co., ltd. is a leading biotechnology firm dedicated to advancing gut health through innovative probiotic solutions. With a robust portfolio of research and development initiatives, the company focuses on formulating high-quality probiotic products that are backed by scientific evidence. Committed to enhancing the well-being of individuals, wecare probiotics collaborates with healthcare professionals and academic institutions to conduct clinical trials that evaluate the efficacy and safety of its formulations. The company's mission is to empower consumers with effective, research-driven probiotic options, fostering a healthier future for all.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0